PBH
Income statement / Annual
Last year (2026), Prestige Consumer Healthcare Inc's total revenue was $1.09 B,
a decrease of 4.31% from the previous year.
In 2026, Prestige Consumer Healthcare Inc's net income was $190.30 M.
See Prestige Consumer Healthcare Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2026
|
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
03/31/2026 |
03/31/2025 |
03/31/2024 |
03/31/2023 |
03/31/2022 |
03/31/2021 |
03/31/2020 |
03/31/2019 |
03/31/2018 |
03/31/2017 |
| Operating Revenue |
$1.09 B |
$1.14 B |
$1.13 B |
$1.13 B |
$1.09 B |
$943.37 M |
$963.01 M |
$975.78 M |
$1.04 B |
$882.06 M |
| Cost of Revenue |
$514.07 M
|
$503.30 M
|
$500.91 M
|
$502.43 M
|
$466.17 M
|
$395.89 M
|
$410.79 M
|
$420.20 M
|
$464.67 M
|
$381.77 M
|
| Gross Profit |
$574.64 M
|
$634.46 M
|
$624.45 M
|
$625.29 M
|
$620.65 M
|
$547.47 M
|
$552.22 M
|
$555.58 M
|
$576.51 M
|
$500.29 M
|
| Gross Profit Ratio |
0.53
|
0.56
|
0.55
|
0.55
|
0.57
|
0.58
|
0.57
|
0.57
|
0.55
|
0.57
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$116.45 M
|
$108.21 M
|
$106.15 M
|
$107.35 M
|
$107.46 M
|
$83.11 M
|
$89.11 M
|
$89.76 M
|
$184.93 M
|
$89.14 M
|
| Selling & Marketing Expenses |
$148.78 M
|
$155.72 M
|
$153.32 M
|
$145.06 M
|
$157.34 M
|
$140.59 M
|
$147.19 M
|
$143.09 M
|
$147.29 M
|
$128.36 M
|
| Selling, General & Administrative Expenses |
$265.23 M
|
$263.93 M
|
$259.47 M
|
$252.42 M
|
$264.80 M
|
$223.70 M
|
$236.31 M
|
$232.85 M
|
$332.21 M
|
$217.50 M
|
| Other Expenses |
$0.00
|
$33.76 M
|
$22.55 M
|
$395.29 M
|
$25.93 M
|
$26.38 M
|
$24.76 M
|
-$476.00 K
|
$28.43 M
|
$25.35 M
|
| Operating Expenses |
$265.23 M
|
$297.69 M
|
$282.02 M
|
$647.71 M
|
$290.73 M
|
$250.07 M
|
$261.07 M
|
$259.90 M
|
$360.64 M
|
$242.85 M
|
| Cost And Expenses |
$779.30 M
|
$800.99 M
|
$782.93 M
|
$1.15 B
|
$756.89 M
|
$645.96 M
|
$671.86 M
|
$680.10 M
|
$825.31 M
|
$624.63 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$342.00 K
|
$217.00 K
|
$388.00 K
|
$203.00 K
|
| Interest Expense |
$42.34 M
|
$47.63 M
|
$67.16 M
|
$69.16 M
|
$64.29 M
|
$82.33 M
|
$96.57 M
|
$105.30 M
|
$106.27 M
|
$93.55 M
|
| Depreciation & Amortization |
$31.27 M
|
$30.17 M
|
$30.68 M
|
$32.63 M
|
$32.09 M
|
$30.16 M
|
$37.78 M
|
$31.78 M
|
$33.43 M
|
$25.79 M
|
| EBITDA |
$331.11 M |
$361.99 M |
$373.86 M |
$7.87 M |
$358.84 M |
$316.61 M |
$325.50 M |
$98.81 M |
$355.72 M |
$304.46 M |
| EBITDA Ratio |
0.3
|
0.32
|
0.33
|
0.01
|
0.33
|
0.34
|
0.34
|
0.1
|
0.34
|
0.35
|
| Operating Income Ratio |
0.28
|
0.3
|
0.3
|
-0.02
|
0.3
|
0.32
|
0.3
|
0.07
|
0.21
|
0.23
|
| Total Other Income/Expenses Net |
-$51.91 M
|
-$52.59 M
|
-$66.40 M
|
-$71.50 M
|
-$67.46 M
|
-$93.29 M
|
-$100.00 M
|
-$105.56 M
|
-$108.39 M
|
-$94.79 M
|
| Income Before Tax |
$257.50 M
|
$284.19 M
|
$276.03 M
|
-$93.92 M
|
$262.46 M
|
$204.11 M
|
$191.15 M
|
-$38.06 M
|
$107.09 M
|
$110.85 M
|
| Income Before Tax Ratio |
0.24
|
0.25
|
0.25
|
-0.08
|
0.24
|
0.22
|
0.2
|
-0.04
|
0.1
|
0.13
|
| Income Tax Expense |
$67.20 M
|
$69.58 M
|
$66.69 M
|
-$11.61 M
|
$57.08 M
|
$39.43 M
|
$48.87 M
|
-$2.26 M
|
-$232.48 M
|
$41.46 M
|
| Net Income |
$190.30 M
|
$214.61 M
|
$209.34 M
|
-$82.31 M
|
$205.38 M
|
$164.68 M
|
$142.28 M
|
-$35.80 M
|
$339.57 M
|
$69.40 M
|
| Net Income Ratio |
0.17
|
0.19
|
0.19
|
-0.07
|
0.19
|
0.17
|
0.15
|
-0.04
|
0.33
|
0.08
|
| EPS |
3.93 |
4.32 |
4.21 |
-1.65 |
4.09 |
3.28 |
2.81 |
-0.69 |
6.34 |
1.31 |
| EPS Diluted |
3.91 |
4.29 |
4.17 |
-1.65 |
4.04 |
3.25 |
2.78 |
-0.69 |
6.34 |
1.3 |
| Weighted Average Shares Out |
$48.46 M
|
$49.70 M
|
$49.76 M
|
$49.88 M
|
$50.26 M
|
$50.21 M
|
$50.72 M
|
$51.88 M
|
$53.10 M
|
$52.98 M
|
| Weighted Average Shares Out Diluted |
$48.72 M
|
$50.08 M
|
$50.18 M
|
$49.89 M
|
$50.84 M
|
$50.61 M
|
$51.14 M
|
$52.07 M
|
$53.53 M
|
$53.36 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
